![[Management of cannabinoid hyperemesis syndrome].](https://cedclinic.com/wp-content/uploads/2026/04/tmpogv1rfsb.jpg "[Management of cannabinoid hyperemesis syndrome]. 1")
| Journal | Revue medicale suisse |
| Study Type | Clinical Study |
| Population | Human participants |
CHS represents a paradoxical condition where cannabis, typically antiemetic, causes severe nausea and vomiting in chronic users. With increasing cannabis legalization and use, clinicians need to recognize this syndrome to avoid misdiagnosis and provide appropriate care.
This clinical review examines cannabinoid hyperemesis syndrome, affecting approximately one-third of regular cannabis users with characteristic cyclic vomiting, nausea, and abdominal pain. The pathognomonic hot water bathing behavior provides temporary relief and serves as a key diagnostic clue. The article reviews current understanding of CHS pathophysiology, likely involving dysregulation of the endocannabinoid system and hypothalamic thermoregulation, though mechanisms remain incompletely understood. Treatment centers on cannabis cessation, with supportive care during acute episodes.
“In my practice, I’ve observed CHS becoming increasingly common as cannabis potency and frequency of use have risen. The hot shower sign remains the most reliable clinical indicator, and I emphasize to patients that complete cannabis cessation is the only definitive treatment.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is cannabinoid hyperemesis syndrome and who does it affect?
- What is the characteristic behavioral sign that helps diagnose CHS?
- How should emergency physicians approach suspected CHS cases?
- What is the most effective treatment for cannabinoid hyperemesis syndrome?
- Why is CHS becoming increasingly important for clinicians to recognize?
FAQ
What is cannabinoid hyperemesis syndrome and who does it affect?
Cannabinoid hyperemesis syndrome (CHS) is a condition characterized by recurrent episodes of vomiting, nausea, and abdominal pain in cannabis users. It affects approximately one-third of regular cannabis users, making it a significant clinical concern in areas with high cannabis usage.
What is the characteristic behavioral sign that helps diagnose CHS?
The pathognomonic feature of CHS is that patients find temporary relief from their symptoms by taking hot baths or showers. This unique behavioral pattern is highly specific to CHS and helps differentiate it from other causes of cyclic vomiting.
How should emergency physicians approach suspected CHS cases?
Emergency physicians should maintain a high index of suspicion for CHS in patients presenting with cyclic vomiting who have a history of regular cannabis use. The key diagnostic clue is asking about compulsive hot bathing or showering for symptom relief, which patients may not volunteer spontaneously.
What is the most effective treatment for cannabinoid hyperemesis syndrome?
The most effective long-term treatment for CHS is complete cessation of cannabis use. While symptomatic treatments may provide temporary relief during acute episodes, only discontinuation of cannabis prevents recurrent episodes and resolves the syndrome.
Why is CHS becoming increasingly important for clinicians to recognize?
With increasing cannabis legalization and usage, CHS is becoming more prevalent and represents an emerging clinical challenge. Early recognition can prevent unnecessary diagnostic workups and hospitalizations while enabling appropriate counseling about cannabis cessation.